Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Volunteer Study

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Laura Mazuera) · xenon@mgb.org · 617-732-6573
Contact: Principal Investigator (Howard L Weiner, MD)
Chris Connor, MD (Sub-investigator)

Study leads

Ilya Ilin, PhD
Principal Investigator
General Biophysics
Howard L Weiner, MD
Principal Investigator
Brigham and Women"s Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of LY4065967 in Healthy Participants

Healthy

Abroad (travel likely)RecruitingPHASE1

Daytona Beach, United States · Dallas, United States

A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants

Healthy Volunteer

Abroad (travel likely)RecruitingPHASE1

Anaheim, United States · Miami, United States

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Healthy Volunteer Study · Healthy Adults · Healthy Participants

Abroad (travel likely)RecruitingPHASE1

New Haven, United States

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

Healthy Volunteer

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia